search
Back to results

Effect of Inulin-type Fructans on Constipated Children. (CONSTICHILD)

Primary Purpose

Constipation

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
OraftiR inulin-type fructans
Placebo
Sponsored by
Institut Investigacio Sanitaria Pere Virgili
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Constipation

Eligibility Criteria

2 Years - 5 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Two to 5 year-old constipated children with sufficient toilet training.
  • To acomplish the Romee I criteria for infants up to 4 yeras. Briefly: have to fulfil at least 2 of the following criteria for at least 1 month:

    1. Two or fewer defecations per week
    2. At least 1 episode per week of incontinence after the acquisition of toileting skills
    3. History of excessive stool retention
    4. History of painful or hard bowel movements
    5. Presence of a large faecal mass in the rectum
    6. History of large-diameter stools that may obstruct the toilet Accompanying symptoms may include irritability, decreased appetite and/or early satiety. Accompanying symptoms disappear immediately following passage of a large stool.

Exclusion Criteria:

  • No child's control of defecation (use of diapers).
  • No mother's command of any local language.
  • Organic causes of defecation disorders incl. Hirschsprung's disease, Spina bifida, hypothyroidism, celiac disease etc.
  • Other metabolic or renal abnormalities or mental retardation (Child's mental delay).
  • Use of drugs (e.g. antibiotics) and labelled pre- and probiotics influencing gastrointestinal function (4 weeks before run-in, 6 weeks before intervention).
  • Use of laxatives in the previous 2 weeks before the beginning of run-in (4 weeks before intervention).

Sites / Locations

  • Iispv- Hospital Sant Joan de Reus

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Placebo

Inulin-type fructans

Arm Description

Maltodextrin 2g, twice per day, 6 weeks

Orafti inulin-type fructans 2g, twice per day, 6 weeks

Outcomes

Primary Outcome Measures

Stool consistency (Assessed by a continuous daily bowel diary over the following period and in accordance with the Modified Bristol Stool Form Scale for Children)

Secondary Outcome Measures

Stool frequency (Assessed by a continuous daily bowel diary and expressed as stools per week)
Abdominal pain (Assessed by daily bowel diary and Wong-Baker FACES Pain Rating Scale)
Pain during defecation (Assessed by daily bowel diary and Wong-Baker FACES Pain Rating Scale)

Full Information

First Posted
April 4, 2016
Last Updated
August 8, 2016
Sponsor
Institut Investigacio Sanitaria Pere Virgili
Collaborators
Beneo GmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT02863848
Brief Title
Effect of Inulin-type Fructans on Constipated Children.
Acronym
CONSTICHILD
Official Title
Effect of Inulin-type Fructans on Constipated Children. Pilot Study.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
September 2012 (undefined)
Primary Completion Date
September 2013 (Actual)
Study Completion Date
January 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institut Investigacio Sanitaria Pere Virgili
Collaborators
Beneo GmbH

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The main objective of this Pilot study was to assess the beneficial effects of a daily supplementation with Orafti inulin-type fructans in 2-5 year old constipated children The study is primary aimed to develop a feasibility study to assess the beneficial effect of inulin-type fructans in the described population with regard to the adequate criteria for a larger trial. Secondary objectives are to obtain data about the feasibility of the protocol (as pilot study). To obtain data useful to perform sample size calculations for a big study designed specifically to investigate the beneficial effect of inulin-type fructans in the treatment of constipated children. Study design and subjects: Double-blind, randomized, placebo-controlled parallel group trial; where 2-5 year-old constipated children received inulin-type fructans or the same amount of placebo (maltodextrin) during 6 weeks. The study protocol was approved by the local Ethical Committees. Outcomes: primary outcome was stool consistency. Secondary outcomes were: stool frequency, gastrointestinal symptoms (abdominal pain and pain during defecation), additional medication required (yes/no), and colonic transit time. Stool samples at baseline, end of intervention and after follow-up were obtained in order to be analysed to know about the microbiota. Dietary intake was also recorded at baseline, end of intervention and after follow-up. Principal subject inclusion criteria: Subjects were recruited if fulfil the Rome III constipation criteria (Mainly hard stools plus stool retention, or pain, or low frequency). Principal subject exclusion criteria: Age under 2 or over 5 years, diapers use, use of laxative during the study and 2 weeks before, use of pre- probiotics or antibiotics during the study and 4 weeks before, organic causes of defecation disorders, other metabolic or renal abnormalities or mental retardation, no parent's command of any local language.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Constipation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Maltodextrin 2g, twice per day, 6 weeks
Arm Title
Inulin-type fructans
Arm Type
Active Comparator
Arm Description
Orafti inulin-type fructans 2g, twice per day, 6 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
OraftiR inulin-type fructans
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
maltodextrin
Primary Outcome Measure Information:
Title
Stool consistency (Assessed by a continuous daily bowel diary over the following period and in accordance with the Modified Bristol Stool Form Scale for Children)
Time Frame
6 weeks of treatment
Secondary Outcome Measure Information:
Title
Stool frequency (Assessed by a continuous daily bowel diary and expressed as stools per week)
Time Frame
6 weeks of treatment
Title
Abdominal pain (Assessed by daily bowel diary and Wong-Baker FACES Pain Rating Scale)
Time Frame
6 weeks of treatment
Title
Pain during defecation (Assessed by daily bowel diary and Wong-Baker FACES Pain Rating Scale)
Time Frame
6 weeks of treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Two to 5 year-old constipated children with sufficient toilet training. To acomplish the Romee I criteria for infants up to 4 yeras. Briefly: have to fulfil at least 2 of the following criteria for at least 1 month: Two or fewer defecations per week At least 1 episode per week of incontinence after the acquisition of toileting skills History of excessive stool retention History of painful or hard bowel movements Presence of a large faecal mass in the rectum History of large-diameter stools that may obstruct the toilet Accompanying symptoms may include irritability, decreased appetite and/or early satiety. Accompanying symptoms disappear immediately following passage of a large stool. Exclusion Criteria: No child's control of defecation (use of diapers). No mother's command of any local language. Organic causes of defecation disorders incl. Hirschsprung's disease, Spina bifida, hypothyroidism, celiac disease etc. Other metabolic or renal abnormalities or mental retardation (Child's mental delay). Use of drugs (e.g. antibiotics) and labelled pre- and probiotics influencing gastrointestinal function (4 weeks before run-in, 6 weeks before intervention). Use of laxatives in the previous 2 weeks before the beginning of run-in (4 weeks before intervention).
Facility Information:
Facility Name
Iispv- Hospital Sant Joan de Reus
City
Reus
State/Province
Tarragona
ZIP/Postal Code
E43204
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Results about the pilot study will be published.
Citations:
PubMed Identifier
27931142
Citation
Closa-Monasterolo R, Ferre N, Castillejo-DeVillasante G, Luque V, Gispert-Llaurado M, Zaragoza-Jordana M, Theis S, Escribano J. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study. Int J Food Sci Nutr. 2017 Aug;68(5):587-594. doi: 10.1080/09637486.2016.1263605. Epub 2016 Dec 8.
Results Reference
derived

Learn more about this trial

Effect of Inulin-type Fructans on Constipated Children.

We'll reach out to this number within 24 hrs